ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

カルシポトリオール

Calcipotriol

HCID 5288783
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
112828-00-9
標準SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
InChIKey
LWQQLNNNIPYSNX-UROSTWAQSA-N
分子式
C27H40O3
平均分子量
412.6 g/mol
単同位体質量
412.29774514

概要

Calcipotriol is a seco-cholestane that is 26,27-cyclo-9,10-secocholesta-5,7,10,22-tetraene carrying additional hydroxy substituents at positions 1, 3 and 24. It is used (as its hydrate) in combination with betamethasone dipropionate, a corticosteroid, for the topical treatment of plaque psoriasis in adult patients. It has a role as an antipsoriatic and a drug allergen. It is a triol, a secondary alcohol, a seco-cholestane, a hydroxy seco-steroid and a member of cyclopropanes.

名称と識別子

優先名称
Calcipotriol
IUPAC
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
現地名
カルシポトリオール
英語名
Calcipotriene
分子式
C27H40O3
分子量
412.6

名称と別名

Calcipotriolcalcipotriene112965-21-6DovonexCalciptriolDaivonexCalcitreneMC-903Calcipotriol anhydrousPRI-2201DTXSID0046648CHEBI:50749
名称をさらに表示
トボネックスドボネックスダイボネックス1α,24(OH)2-22-エン-24-シクロプロピル-D3(5Z,7E,22E,24S)-24-シクロプロピル-9,10-セココラ-5,7,10(19),22-テトラエン-1α,3β,24-トリオールカルシポトリエンカルシポトリオール(5Z,7E,22E,24S)-9,10-セコ-26,27-シクロコレスタ-5,7,10(19),22-テトラエン-1α,3β,24-トリオールダイボベット(22E,24S)-1α,24-ジヒドロキシ-26,27-シクロ-22,23-ジデヒドロコレカルシフェロールカルシポトリオール 水和物カルシポトリオール (JAN)Calcipotriol hydrateDaivobetcipotrieneCalcipotrio
143NQ3779B(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diolMC903(1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E,24S)-DTXCID8026648calcipotriolocalcipotriolum

物性

構造計算による物性

XLogP
4.3
極性表面積
60.7 Ų
水素結合供与体数
3
水素結合受容体数
3
回転可能結合数
5
重原子数
30
形式電荷
0
複雑度
743

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LipidsLipids -> Sterol Lipids [ST] -> Secosteroids [ST03] -> Vitamin D3 and derivatives [ST0302]
Solubility1.35e-02 g/L
Human Drugs · 4 件

Breast Feeding; Lactation; Milk, Human; Dermatologic Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Dermatological medicines > Medicines affecting skin differentiation and proliferation

Physical DescriptionSolid

物理化学的性質

融点
166 · 166-168°C
沸点
582 · 582.0±50.0 °C(Predicted)
比重(密度)
1.12 · 1.12±0.1 g/cm3(Predicted)
貯蔵温度
-20 °C · Desiccate at -20°C
溶解性
15 mg/mL、透明 · DMSO:可溶15mg/mL、透明
外見
粉
酸解離定数(Pka)
14.29 · 14.29±0.20(Predicted)
色
White to off-white

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Danger

H300+H310 (16.7%): Fatal if swallowed or in contact with skin [Danger Acute toxicity, oral; acute toxicity, dermal]

P203, P260, P261, P262, P263, P264, P264+P265, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P318, P319, P320, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 6 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

危険有害性情報

Hazard Classes and Categories · 2 件

Acute Tox. 2 (83.3%)

Acute Tox. 3 (100%)

毒性情報

Exposure Routes · 1 件

Clinical studies with radiolabeled ointment indicate that approximately 6% (+3%, SD) of the applied dose of calcipotriene is absorbed systemically when the ointment is applied topically to psoriasis plaques or 5% (+2.6%, SO) when applied to normal skin.

Toxicity Summary · 1 件

The precise mechanism of calcipotriol in remitting psoriasis is not well-understood. However, it has been shown to have comparable affinity with calcitriol for the Vitamin D receptor, while being less than 1% as active as the calcitriol in regulating calcium metabolism. The Vitamin D receptor (VDR) belongs to the steroid/thyroid receptor superfamily, and is found on the cells of many different tissues including the thyroid, bone, kindney, and T cells of the immune system. T cells are known to play a role in psoriasis, and it is thought that the binding of calcipotriol to the VDR modulates the T cells gene transcription of cell differentiation and proliferation related genes.

化学と産業

薬理情報

ATC Code · 4 件

D05AX52

D - Dermatologicals

QD - Dermatologicals

D05AX02

PharmacodynamicsCalcipotriene is a synthetic analog of vitamin D. In humans, the natural supply of vitamin D depends mainly on exposure to the ultraviolet rays of the sun for conversion of 7-dehydrocholesterol to vitamin D3 (cholecalciferol) in the skin.
Mechanism of Action · 1 件

The precise mechanism of calcipotriol in remitting psoriasis is not well-understood, however, it has been shown to have comparable affinity with calcitriol for the Vitamin D receptor while being less than 1% the activity in regulating calcium metabolism. The Vitamin D receptor (VDR) belongs to the steroid/thyroid receptor superfamily, and is found on the cells of many different tissues including the thyroid, bone, kindney, and T cells of the immune system. T cells are known to play a role in psoriasis and are believed to undergo modulation of gene expression with binding of calcipotriol to the VDR. This modulation is thought to affect gene products related to cell differentiation and proliferation.

Metabolism/Metabolites · 2 件

Hepatic. Calcipotriene metabolism following systemic uptake is rapid, and occurs via a similar pathway to the natural hormone. The primary metabolites are much less potent than the parent compound.

Hepatic. Calcipotriene metabolism following systemic uptake is rapid, and occurs via a similar pathway to the natural hormone. The primary metabolites are much less potent than the parent compound. Route of Elimination: The active form of the vitamin, 1,25-dihydroxy vitamin D3 (calcitriol), is known to be recycled via the liver and excreted in the bile. There is evidence that maternal 1,25-dihydroxy vitamin D3 (calcitriol) may enter the fetal circulation, but it is not known whether it is excreted in human milk.

FDA Pharmacological Classification · 6 件

143NQ3779B

CALCIPOTRIENE

Chemical Structure [CS] - Vitamin D

Established Pharmacologic Class [EPC] - Vitamin D Analog

Calcipotriene is a Vitamin D Analog.

関連反応

2 件
反応記録を作成
HRID 348784 の反応式
HRID 348784反応物として
HRID 553331 の反応式
HRID 553331反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
112828-00-9、112965-21-6
PubChem CID
5288783
DTXSID
DTXSID0046648
ChEMBL
CHEMBL1200666
ChEBI
CHEBI:50749
UNII
143NQ3779B
EC Number
601-218-4、686-849-3
Nikkaji
J367.434G
安定性
Light and Temperature Sensitive, Light And Temperature Sensitive
InChIKey
LWQQLNNNIPYSNX-HCHVWAPNSA-N
SMILES
[C@@H]1(O)C/C(=C/C=C2\CCC[C@@]3(C)[C@@]\2([H])CC[C@@H]3[C@H](C)/C=C/[C@H](C2CC2)O)/C(=C)[C@@H](O)C1
CAS データベース
112965 · 112965-21-6(CAS DataBase Reference)

化学的性質

化学的特性White Crystalline Solid

Signs and SymptomsTopically applied calcipotriene can be absorbed in sufficient amounts to produce systemic effects. Elevated serum calcium has been observed with excessive use of calcipotriene.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk
3
ridadr
UN 2811 6.1 / PGIII
毒性
dog,LD50,skin,> 1500ug/kg (1.5mg/kg),BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)MUSCULOSKELETAL: OTHER CHANGESGASTROINTESTINAL: NAUSEA OR VOMITING,Journal of Toxicological Sciences. Vol. 21(Suppl,
hs_code
2906195000
risk_code
36/37/38
hazard_code
Xi
safety_code
26
Hazard Classifications
Acute Tox. 1 DermalAcute Tox. 2 OralEye Irrit. 2Repr. 2Skin Sens. 1BSTOT RE 1
ストレージクラス
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials

CALCIPOTRIENE

MeSH Pharmacological ClassificationDrugs used to treat or prevent skin disorders or for the routine care of skin.
Absorption, Distribution and Excretion · 2 件

Clinical studies with radiolabeled ointment indicate that approximately 6% (+3%, SD) of the applied dose of calcipotriene is absorbed systemically when the ointment is applied topically to psoriasis plaques or 5% (+2.6%, SO) when applied to normal skin.

The active form of the vitamin, 1,25-dihydroxy vitamin D3 (calcitriol), is known to be recycled via the liver and excreted in the bile. There is evidence that maternal 1,25-dihydroxy vitamin D3 (calcitriol) may enter the fetal circulation, but it is not known whether it is excreted in human milk.

Cellular LocationsCytoplasm

用途と製造

Uses · 2 件

Use (kg) in USA (2002): 4

For the treatment of moderate plaque psoriasis in adults.

応用分野 · 2 件

説明Calcipotriene also known as Calcipotriol, is a topical vitaminD3 derivative effective in the treatment of psoriasis vulgaris. The drug acts by binding to vitamin D3 receptors in the skin keratinocytes, producing an elevation in cell differentiation and a reduction in cell proliferation. Although its efficacy is comparable to calcitriol, calcipotriol exhibits at least 100 times less effect on calcium metabolism in rats.

使用Calcipotriene is an antipsoriatic that is a vitamin D3 analogue with low calcemic activity. It works by regulating the production and growth of skin cells. In the United States, this drug was first marketed under the trade name Dovonex and is used mainly for the treatment of psoriasis. It is one of the most effective non glucocorticoid topical drugs for the treatment of localized psoriasis.This drug has many off-label applications that are alternative therapies for many dermatologic diseases.

調製方法 · 1 件

製造方法A convergent approach for the total synthesis of calcipotriol (brand name: Dovonex), a proven Vitamin D analog used for the treatment of psoriasis, and medicinally relevant synthetic analogs is described.A Synthesis of calcipotriol via a Key Electroreductive Cross-coupling ApproachCalcipotriol is currently the most successful VitD analog and is prescribed for the treatment of psoriasis, an autoimmune skin disease.

上流・下流製品情報

上流原料

Liquid sulfur dioxidetert-ブチルジメチルクロロシラン4-Methylmorpholine-4-oxide solutionセレン(IV)ジオキシドテトラブチルアンモニウムフルオリド (1mol/Lテトラヒドロフラン溶液)アントラセンシクロプロピルマグネシウムブロミド (15%テトラヒドロフラン溶液, 約1mol/L)トリエチルアミン水素化ほう素ナトリウム塩化セリウム(III) (無水)Phosphine oxide, [2-[3,5-bis [[(1,1-dimethylethyl) dimethylsily]oxy]-2-methylenecyclohexylidene]ethyl]diphenyl-,[3s-(1z,3a,5b0)]1,3-ビス-O-(TERT-ブチルジメチルシリル)カルシポトリエン(5E)-Calcipotriene

下流製品

(22E,24R)-1α,24-ジヒドロキシ-26,27-シクロ-22,23-ジデヒドロコレカルシフェロール
補足説明 · 1 件

定義ChEBI: Calcipotriol is a seco-cholestane that is 26,27-cyclo-9,10-secocholesta-5,7,10,22-tetraene carrying additional hydroxy substituents at positions 1, 3 and 24. It is used (as its hydrate) in combination with betamethasone dipropionate, a corticosteroid, for the topical treatment of plaque psoriasis in adult patients. It has a role as a drug allergen and an antipsoriatic. It is a member of cyclopropanes, a secondary alcohol, a triol, a hydroxy seco-steroid and a seco-cholestane.